Calendar

Oct
13
Thu
SUMMIT #1 @ Sheraton Grand Los Angeles
Oct 13 @ 6:30 pm – 8:30 pm

Sheraton Grand Los Angeles
711 Hope Street, Los Angeles.
ROOM NAME: Wiltern Room.

PROGRAM FEATURES

Virtual reality headsets provided to enhance learning experience
Case-based learning environment

FACULTY

April Armstrong, MD
Associate Professor of Clinical Dermatology
Associate Dean For Clinical Research
Keck School of Medicine of USC
Los Angeles, CA

Andrew Blauvelt, MD, MBA
President and Investigator
Oregon Medical Research Center
Portland, OR

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

Review recent advances in the understanding of psoriasis pathophysiology
Explain the link between psoriasis and cardiovascular disease and the rationale and evidence for screening and management of cardiovascular disease in patients with psoriasis
Describe the mechanisms of action of new and emerging biologics for psoriasis and critically evaluate their efficacy/safety profile in patients with moderate to severe psoriasis
Discuss the impact of approved and investigational biologics on kinetics of responses, skin clearance, patients’ symptoms and quality of life, and how to individualize psoriasis management based on these factors

TARGET AUDIENCE

This activity is intended for dermatologists and other healthcare professionals involved in the management of patients with psoriasis.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose:

This program would be beneficial for nurses involved in the care of patients with psoriasis.

Credits:

2.0 ANCC Contact Hour(s)

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 2.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

This activity is provided by Med Learning Group.

image005

This activity was co-provided by Ultimate Medical Academy/CCM.

ccm-uma-300x86

Supported by an Educational Grant from Eli Lilly.

Copyright © 2016 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Oct
14
Fri
SDEF Women’s Symposium @ Hyatt Regency
Oct 14 @ 4:45 pm – 5:45 pm

Hyatt Regency
1107 Jamboree Rd, Newport Beach, CA 92660

PROGRAM FEATURES

  • Virtual reality headsets provided to enhance learning experience
  • Case-based learning environment

FACULTY

Andrew Blauvelt, MD, MBA
President and Investigator
Oregon Medical Research Center
Portland, OR

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Review recent advances in the understanding of psoriasis pathophysiology
  • Explain the link between psoriasis and cardiovascular disease and the rationale and evidence for screening and management of cardiovascular disease in patients with psoriasis
  • Describe the mechanisms of action of new and emerging biologics for psoriasis and critically evaluate their efficacy/safety profile in patients with moderate to severe psoriasis
  • Discuss the impact of approved and investigational biologics on kinetics of responses, skin clearance, patients’ symptoms and quality of life, and how to individualize psoriasis management based on these factors

TARGET AUDIENCE

This activity is intended for dermatologists and other healthcare professionals involved in the management of patients with psoriasis.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose:

This program would be beneficial for nurses involved in the care of patients with psoriasis.

Credits:

1.0 ANCC Contact Hour(s)

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

This activity is provided by Med Learning Group.

image005

This activity was co-provided by Ultimate Medical Academy/CCM.

ccm-uma-300x86

Supported by an Educational Grant from Eli Lilly.

Copyright © 2016 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Oct
18
Tue
SUMMIT #2 @ Courtyard Marriott Downtown Philadelphia
Oct 18 @ 6:30 pm – 8:30 pm

Courtyard Marriott Downtown Philadelphia
21 N Juniper St. Philadelphia, PA
ROOM NAME: Grand Ballroom

PROGRAM FEATURES

  • Virtual reality headsets provided to enhance learning experience
  • Case-based learning environment

FACULTY

Joel M. Gelfand MD, MSCE
Clinical Associate Professor of Dermatology and Epidemiology
University of Pennsylvania
Philadelphia, PA

Junko Takeshita, MD, PhD
Clinical Instructor Dept. of Dermatology
University of Pennsylvania
Philadelphia, PA

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Review recent advances in the understanding of psoriasis pathophysiology
  • Explain the link between psoriasis and cardiovascular disease and the rationale and evidence for screening and management of cardiovascular disease in patients with psoriasis
  • Describe the mechanisms of action of new and emerging biologics for psoriasis and critically evaluate their efficacy/safety profile in patients with moderate to severe psoriasis
  • Discuss the impact of approved and investigational biologics on kinetics of responses, skin clearance, patients’ symptoms and quality of life, and how to individualize psoriasis management based on these factors

TARGET AUDIENCE

This activity is intended for dermatologists and other healthcare professionals involved in the management of patients with psoriasis.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose:

This program would be beneficial for nurses involved in the care of patients with psoriasis.

Credits:

2.0 ANCC Contact Hour(s)

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 2.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

This activity is provided by Med Learning Group.

image005

This activity was co-provided by Ultimate Medical Academy/CCM.

ccm-uma-300x86

Supported by an Educational Grant from Eli Lilly.

Copyright © 2016 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Nov
2
Wed
SDPA 14th Annual Fall Dermatology Conference @ Caesar’s Palace Las Vegas
Nov 2 @ 5:30 pm – 6:30 pm

Caesar’s Palace Las Vegas
3570 S Las Vegas Blvd, Las Vegas, NV 89109
ROOM NAME: Pisa/Palermo Ballroom-Promenade Level

PROGRAM FEATURES

  • Virtual reality headsets provided to enhance learning experience
  • Case-based learning environment

FACULTY

Junko Takeshita, MD, PhD
Clinical Instructor Dept. of Dermatology
University of Pennsylvania
Philadelphia, PA

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Review recent advances in the understanding of psoriasis pathophysiology
  • Explain the link between psoriasis and cardiovascular disease and the rationale and evidence for screening and management of cardiovascular disease in patients with psoriasis
  • Describe the mechanisms of action of new and emerging biologics for psoriasis and critically evaluate their efficacy/safety profile in patients with moderate to severe psoriasis
  • Discuss the impact of approved and investigational biologics on kinetics of responses, skin clearance, patients’ symptoms and quality of life, and how to individualize psoriasis management based on these factors

TARGET AUDIENCE

This activity is intended for dermatologists and other healthcare professionals involved in the management of patients with psoriasis.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose:

This program would be beneficial for nurses involved in the care of patients with psoriasis.

Credits:

1.0 ANCC Contact Hour(s)

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

This activity is provided by Med Learning Group.

image005

This activity was co-provided by Ultimate Medical Academy/CCM.

ccm-uma-300x86

Supported by an Educational Grant from Eli Lilly.

Copyright © 2016 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Nov
11
Fri
SDEF 17th Annual Las Vegas Dermatology Seminar @ The Cosmopolitan of Las Vegas
Nov 11 @ 7:00 am – 8:00 am

The Cosmopolitan of Las Vegas
3708 S Las Vegas Blvd,
Las Vegas, NV 89109
Room Name: BELMONT

PROGRAM FEATURES

  • Virtual reality headsets provided to enhance learning experience
  • Case-based learning environment

FACULTY

Joel M. Gelfand MD, MSCE
Clinical Associate Professor of Dermatology and Epidemiology
University of Pennsylvania
Philadelphia, PA

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Review recent advances in the understanding of psoriasis pathophysiology
  • Explain the link between psoriasis and cardiovascular disease and the rationale and evidence for screening and management of cardiovascular disease in patients with psoriasis
  • Describe the mechanisms of action of new and emerging biologics for psoriasis and critically evaluate their efficacy/safety profile in patients with moderate to severe psoriasis
  • Discuss the impact of approved and investigational biologics on kinetics of responses, skin clearance, patients’ symptoms and quality of life, and how to individualize psoriasis management based on these factors

TARGET AUDIENCE

This activity is intended for dermatologists and other healthcare professionals involved in the management of patients with psoriasis.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose:

This program would be beneficial for nurses involved in the care of patients with psoriasis.

Credits:

1.0 ANCC Contact Hour(s)

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

This activity is provided by Med Learning Group.

image005

This activity was co-provided by Ultimate Medical Academy/CCM.

ccm-uma-300x86

Supported by an Educational Grant from Eli Lilly.

Copyright © 2016 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Jan
21
Sat
The 16th Annual Caribbean Dermatology Conference @ Hilton Aruba Caribbean Resort and Casino
Jan 21 @ 7:00 am – 8:00 am

Hilton Aruba Caribbean Resort and Casino
J.E. Irausquin Blvd 81,
Noord, Aruba

Jan
30
Mon
Symposium – 41st SDEF Hawaii Dermatology Seminar @ Grand Wailea Hotel
Jan 30 @ 6:30 am – 7:30 am

Grand Wailea Hotel
3850 Wailea Alanui Dr., Wailea, HI 96753

Faculty: 
Andrew Blauvelt, MD, MBA
President and Investigator
Oregon Medical Research Center
Portland, OR

Feb
22
Thu
Summit Meeting @ Miami Marriott Biscayne Bay
Feb 22 @ 7:00 am – 8:00 am

Miami Marriott Biscayne Bay
Miami, FL
6:30 – 7:00 PM  Dinner / Registration
7:00 – 8:00 PM CME Summit Meeting

Presenter is Joel Gelfand, MD of University of Pennsylvania in Philadelphia, PA.